Tom Gallen

Tom Gallen

Managing Editor, Europe

Birmingham, UK

Tom reports and edits European consumer health care industry news and analysis. Leading HBW Insight’s health and wellness coverage in Europe, he has been writing about the sector since 2013. Tom’s main focus is analyzing the strategies of the world's leading consumer healthcare companies, their business performance, plans and product portfolios. He also reports on regulatory topics such as novel foods and prescription-to-OTC switches.

Latest from Tom Gallen

Stada Acquires Fortacell To Grow In Balkans

Stada's Serbian subsidiary Hemofarm has enhanced its offering in the dietary supplements category with the acquisition of Fortacell from Goodwill Pharma.

People On The Move: Appointments At Opella, Stada, Futura

Latest European appointments: Opella names Germany director; Stada has new Western Europe head; Futura makes CEO change.

Vision Healthcare Strikes Deals To Expand European Offering

Belgium-based Vision Healthcare has acquired Svenskt Kosttillskott in Sweden and New Care Supplements in the Netherlands.

Perrigo Implements Streamlining Plan With Sale Of Dermacosmetics

Perrigo stands to gain up to €327m with sale of brands such as ACO and Emolium to KKR.

Lupin Goes For Growth With Indian Consumer Health Spin-Off

With annual sales approaching $20m, LupinLife Consumer Healthcare has ambitious growth plans for the Indian OTC market.

AstaReal Launches Membralife Supplement Following CEO Change

Designed to help moisturize the body’s mucous membranes, the Membralife supplement is now available in Sweden. The launch comes with AstaReal now under new management following the appointment of Daniel Flodqvist as CEO.